Skip to main content

Find Clinical Trials

Home
Conditions
Melanoma

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

1,022 public trials 170 recruiting studies

Refine in advanced search Browse all conditions

Melanoma trial results

Recruiting

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

NCT06814496

Conditions: Adenocarcinoma, Astrocytoma, Bladder Cancer, +74 more
Locations: Arizona Cancer Center at UMC North/University Medical Center Tucson, Arizona, United States

University of Washington Fred Hutchinson Cancer Center Seattle, Washington, United States

Banner MD Anderson Cancer Center Gilbert, Arizona, United States

View Trial Details

Recruiting

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

NCT06529822

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +29 more
Locations: AdventHealth Orlando, Florida, United States

Washington University School of Medicine St Louis, Missouri, United States

Ohio State University Columbus, Ohio, United States

View Trial Details

Recruiting

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

NCT04038619

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +50 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors

NCT06398418

Conditions: Adenoma, Basal Cell Cancer, Melanoma, +17 more
Locations: Sarah Cannon Research Institute Nashville, Tennessee, United States

Sarah Cannon Research Institute Denver, Colorado, United States

View Trial Details

Recruiting

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

NCT04752826

Conditions: Adnexal Diseases, Advanced Malignancies, Endocrine Gland Neoplasms, +33 more
Locations: City of Hope National Medical Center Duarte, California, United States

Memorial Sloan Kettering Cancer Center New York, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

Rigshospitalet Copenhagen, Denmark

View all 25 locations

View Trial Details

Recruiting

LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma

NCT06623461

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: BCCA - Abbotsford Abbotsford British Columbia, British Columbia, Canada

BCCA - Surrey Surrey, British Columbia, Canada

BCCA - Vancouver Vancouver, British Columbia, Canada

Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada

View all 15 locations

View Trial Details

Recruiting

A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma

NCT05607095

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +16 more
Locations: Memorial Sloan Kettering Westchester Harrison, New York, United States

Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States

View Trial Details

Recruiting

A Study of BI 3810944 in Patients With Advanced Cancer

NCT07224425

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: University of Louisville Louisville, Kentucky, United States

Tennessee Oncology, PLLC - Elliston Place Plaza DDU Nashville, Tennessee, United States

The University of Texas MD Anderson Cancer Center Houston, Texas, United States

University of Virginia Health System Charlottesville, Virginia, United States

View Trial Details

Recruiting

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma

NCT00040352

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dysplastic Nevus Syndrome, Genetic Diseases, Inborn, +14 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

NCT04899908

Conditions: AGuIX, Brain Cancer, Brain Diseases, +46 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details